TY  - GEN
AU  - Panaccione,R
AU  - Colombel,J-F
AU  - Sandborn,W J
AU  - Rutgeerts,P
AU  - D'Haens,G R
AU  - Robinson,A M
AU  - Chao,J
AU  - Mulani,P M
AU  - Pollack,P F
TI  - Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
SN  - 1365-2036
PY  - 2011///0105
KW  - Adalimumab
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Crohn Disease
KW  - drug therapy
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Quality of Life
KW  - Severity of Illness Index
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2036.2010.04304.x
ER  -